Seemal Desai, M.D., FAAD, discusses how treatment safety and effectiveness must be carefully evaluated through monitoring ...

Prescription of Neurontin (gabapentin) and other gabapentinoids has increased partly because they are viewed as a safer ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

During the COVID-19 pandemic, healthcare workers faced several mental health challenges, experiencing repeated exposure to ...

An intervention program that coaches patients in stress management and goal setting, along with a digital app, helped ...

Gene therapies have a lot of potential to improve health outcomes for patients with life-threatening diseases but face a number of barriers that restrict access.

Lindsay Bealor Greenleaf, JD, MBA; Ryann Hill, MPH; Patrick Cooney ...

After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked ...

A total of 17 lots are now part of the recall of Clonazepam because some cartons have the wrong strength on the label.

The FDA has approved UCB's Bimzelx for moderate-to-severe hidradenitis suppurativa, offering a new treatment option for this ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...